article Open AccessTop 1% cited
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
European Heart Journal · 2005 · Vol. 26(3) · pp. 215–225
Marcus Flather✉(Royal Brompton & Harefield NHS Foundation Trust)Marcelo C. Shibata(Royal Brompton & Harefield NHS Foundation Trust)Andrew J.S. Coats(University of Sydney)Dirk J. van Veldhuisen(University of Groningen)Alexander Parkhomenko(National Academy of Sciences of Ukraine)Joszef Borbola(Gottsegen National Cardiovascular Center)Alain Cohen‐Solal(Hôpital Beaujon)Dan L. DumitraşcuRoberto Ferrari(University of Ferrara)Philippe Lechat(Pitié-Salpêtrière Hospital)Jordi Soler‐SolerLuigi Tavazzi(Policlinico San Matteo Fondazione)Lenka Špinarová(University Hospital Brno)Jiřı́ Toman(University Hospital Brno)Michael Böhm(Universitätsklinikum des Saarlandes)Stefan D. Anker(Charité - Universitätsmedizin Berlin)Simon G. Thompson(Medical Research Council)Philip A. Poole‐Wilson(Imperial College London)
Abstract
Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly.
Heart Failure Treatment and ManagementBlood Pressure and Hypertension StudiesCardiac, Anesthesia and Surgical OutcomesNebivololMedicineEjection fractionHeart failurePlaceboHazard ratioCardiologyInternal medicineRandomized controlled trialConfidence interval
MeSH terms
NebivololAdrenergic beta-AntagonistsAgedAged, 80 and overBenzopyransBlood PressureCause of DeathDouble-Blind MethodEthanolaminesFemaleFollow-Up StudiesHeart FailureHeart RateHumansMale
Funding
- Menarini Group
Citations
1,637
FWCI
60.59
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
European Heart Journal · 2017 · 9,605 citations
2013 ESC guidelines on the management of stable coronary artery disease
European Heart Journal · 2013 · 4,515 citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal · 2021 · 5,933 citations
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · 11,387 citations
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
European Heart Journal · 2005 · 2,257 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
European Heart Journal · 2008 · 2,692 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
European Heart Journal · 2012 · 6,892 citations
2013 ACCF/AHA Guideline for the Management of Heart Failure
Journal of the American College of Cardiology · 2013 · 12,586 citations
References
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
The Lancet · 1999 · 5,094 citations
The epidemiology of heart failure: The Framingham Study
Journal of the American College of Cardiology · 1993 · 2,258 citations
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
European Heart Journal · 2005 · 2,257 citations
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
The Lancet · 1999 · 4,886 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.